Hepatitis C begins as an acute infection, a short-term illness that occurs within six months after someone is infected. The likelihood that HCV infection becomes chronic is approximately 75-85% of cases.2 As a silent disease, HCV can remain asymptomatic in patients for decades, contributing to low diagnosis rates. If left undiagnosed and untreated, chronic HCV infection can lead to serious consequences.
As part of the campaign, OraSure is happy to launch new resources to help you develop and run successful HCV testing programs. We have created a Testing Toolkit that includes materials to help you plan, promote and execute your rapid HCV testing programs.
We urge you to join in our initiative to help more people in the U.S. get tested for HCV. Working together, we encourage those at risk for HCV to get tested, seek treatment and fight HCV.
An estimated 5.2 million people have been infected with or have hepatitis C3 while 3.2 million people in the United States are living with chronic hepatitis C infection2 making it the most common infection of the blood. According to the Centers for Disease Control and Prevention (CDC) approximately 75% (2.4 million) people do not show signs or symptoms they are ill or know they are infected. There are approximately 17,000 new hepatitis C cases each year in the U.S., many of which go unreported.
©2015 OraSure Technologies, Inc. All Rights Reserved.